Effect of induction regimen in survival in newly diagnosed multiple myeloma patients receiving consolidation with autologous stem cell transplantation

被引：0

作者：

Garrido, David ^{[1
]}

von Glassenap, Alana ^{[2
]}

Pena, Camila ^{[3
]}

Martinez-Cordero, Humberto ^{[4
]}

Ramirez-Alvarado, Aline ^{[5
]}

Tarin-Arzaga, Luz ^{[6
,7
]}

Schutz, Natalia ^{[8
,9
]}

Bove, Virginia ^{[10
]}

Sossa, Claudia ^{[11
]}

Yantorno, Sebastian ^{[12
]}

Ochoa, Paola ^{[13
]}

Orlando, Sergio ^{[14
]}

Ladines-Castro, Washington ^{[15
]}

Duarte, Patricio ^{[16
]}

Remaggi, Guillermina ^{[17
]}

Shanley, Claudia ^{[18
]}

Ruiz-Arguelles, Guillermo ^{[19
]}

Fantl, Dorotea ^{[8
,9
]}

Riva, Eloisa ^{[1
]}

机构：

[1] Hosp Clin Dr Manuel Quintela, Montevideo, Uruguay

[2] Inst Previs Social, Asuncion, Paraguay

[3] Hosp Salvador, Santiago, Chile

[4] Inst Nacl Cancerol ESE Colombia, Bogota, Colombia

[5] Inst Mexicano Seguro Social, Ctr Med Nacl La Raza, Mexico City, DF, Mexico

[6] UANL, Serv Hematol, Univ Hosp, Monterrey, Nuevo Leon, Mexico

[7] UANL, Fac Med, Monterrey, Nuevo Leon, Mexico

[8] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina

[9] Ariel Corzo Hosp Clin, Buenos Aires, DF, Argentina

[10] Hosp Cent FFAA, Montevideo, Uruguay

[11] Clin Carlos Ardila Lulle, Bucaramanga, Colombia

[12] Hosp San Martin La Plata, La Plata, Argentina

[13] Inst Alexander Fleming, Buenos Aires, DF, Argentina

[14] Hosp Rossi, La Plata, Argentina

[15] SOLCA Inst Oncol Nacl Guayaquil, Guayaquil, Ecuador

[16] CEMIC, Unidad Trasplante Hematopoyet, Buenos Aires, DF, Argentina

[17] FUNDALEU, Buenos Aires, DF, Argentina

[18] Hospital Britan Buenos Aires, Buenos Aires, DF, Argentina

[19] Mexico Clin Ruiz, Puebla, Mexico

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-176

引用

页码：S132 / S133

页数：2

共 50 条

[21] Comparison of VTD (velcade-thalidomide-dexamethasone) and a conventional chemotherapy induction regimen: effect on stem cell mobilization and engraftment of ASCT (autologous stem cell transplantation) for newly diagnosed multiple myeloma
Requena, M. J.
Yebra, E.
Berberana, M.
Payamps, C.
Diaz Goizueta, M.
Riaza, R.
Penalver, M. A.
Rodriguez, R.
Sanchez Godoy, P.
BONE MARROW TRANSPLANTATION, 2013, 48 : S212 - S213
[22] Autologous stem cell transplantation followed by consolidation chemotherapy for patients with multiple myeloma
Gojo, I
Meisenberg, B
Guo, C
Fassas, A
Murthy, A
Fenton, R
Takebe, N
Heyman, M
Philips, G
Cottler-Fox, M
Sarkodee-Adoo, C
Ruehle, K
French, T
Tan, M
Tricot, G
Rapoport, AP
BONE MARROW TRANSPLANTATION, 2006, 37 (01) : 65 - 72
[23] Autologous stem cell transplantation followed by consolidation chemotherapy for patients with multiple myeloma
I Gojo
B Meisenberg
C Guo
A Fassas
A Murthy
R Fenton
N Takebe
M Heyman
G L Philips
M Cottler-Fox
C Sarkodee-Adoo
K Ruehle
T French
M Tan
G Tricot
A P Rapoport
Bone Marrow Transplantation, 2006, 37 : 65 - 72
[24] RESPONSE AND SURVIVAL IMPROVEMENT WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: DIFFERENT INDUCTION THERAPY IMPACT OVER THE LAST 30 YEARS
Mateos Perez, Jose Miguel
Fernandez-Aviles, Francesc
Fernandez de larrea, Carlos
Teresa Cibeira, Maria
Tovar, Natalia
Martinez, Carmen
Gerardo Rodrigez-Lobato, Luis
Suarez-Lledo, Maria
Queralt Salas, Maria
Rovira, Montserrat
Blade, Joan
Rosinol, Laura
BONE MARROW TRANSPLANTATION, 2024, 59 : 515 - 516
[25] Long term follow up of newly diagnosed multiple myeloma patients treated with pembrolizumab consolidation post-autologous stem cell transplantation
Mohan, Meera
Hari, Parameswaran
Szabo, Aniko
Dhakal, Binod
Chhabra, Saurabh
D'Souza, Anita
LEUKEMIA RESEARCH, 2021, 109
[26] High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma
D Sivaraj
W Bacon
G D Long
D A Rizzieri
M E Horwitz
K M Sullivan
Y Kang
Z Li
N J Chao
C Gasparetto
Bone Marrow Transplantation, 2018, 53 : 34 - 38
[27] Thalidomide-Dexamethasone as Induction Therapy before Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma and Renal Insufficiency
Tosi, Patrizia
Zamagni, Elena
Tacchetti, Paola
Ceccolini, Michela
Perrone, Giulia
Brioli, Annamaria
Pallotti, Maria Caterina
Pantani, Lucia
Petrucci, Alessandro
Baccarani, Michele
Cavo, Michele
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (08) : 1115 - 1121
[28] High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma
Sivaraj, D.
Bacon, W.
Long, G. D.
Rizzieri, D. A.
Horwitz, M. E.
Sullivan, K. M.
Kang, Y.
Li, Z.
Chao, N. J.
Gasparetto, C.
BONE MARROW TRANSPLANTATION, 2018, 53 (01) : 34 - 38
[29] Impact of induction treatment before autologous stem cell transplantation on long-term outcome in patients with newly diagnosed multiple myeloma
Gassiot, Susanna
Motllo, Cristina
Llombart, Inuska
Morgades, Mireia
Gonzalez, Yolanda
Garcia-Caro, Montse
Ribera, Josep-Maria
Oriol, Albert
EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (06) : 569 - 576
[30] Strategies for induction, autologous hematopoietic stem cell transplantation, consolidation, and maintenance for transplantation-eligible multiple myeloma patients
McCarthy, Philip L.
Hahn, Theresa
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 496 - 503

← 1 2 3 4 5 →